Nanobiotix S.A (NBTX)

Etorro trading 970x250
Nanobiotix S.A (NBTX) Logo

About Nanobiotix S.A

Nanobiotix SA operates as a clinical-stage nanomedicine company for the treatment of cancer worldwide. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a radio-enhancer hafnium oxide for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, and other cancers. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012

Nanobiotix S.A News and around…

Latest news about Nanobiotix S.A (NBTX) common stock and company :

NANOBIOTIX Announces 18.1 Month Median Overall Survival for 41 Evaluable Elderly and Frail Patients With HNSCC in Phase I Expansion Evaluating Nbtxr3 as a Single Agent Activated by Radiotherapy
24 Oct, 2021 FinancialContent

Regulatory News:

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
24 Oct, 2021 FinancialContent

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma ...

NANOBIOTIX Provides Third Quarter Operational and Financial Update
20 Oct, 2021 FinancialContent

Regulatory News:

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
08 Oct, 2021 FinancialContent

Regulatory News:

12 Health Care Stocks Moving In Thursday's Intraday Session
07 Oct, 2021 FinancialContent

Gainers Nanobiotix (NASDAQ:NBTX) shares rose 13.2% to $12.0 during Thursday's regular session. The market value of ...

NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program Among Five Presentations at the 2021 Annual Meeting of the American Society for Radiation Oncology
06 Oct, 2021 FinancialContent

Regulatory News:

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
29 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

NANOBIOTIX Announces Red Journal Publication of Preclinical Data Showing Radioenhancer NBTXR3 May “Reprogram” the Tumor Microenvironment to Overcome Anti-PD-1 Resistance and Evoke Abscopal Effect
28 Sep, 2021 FinancialContent

Regulatory News:

NANOBIOTIX Announces Red Journal Publication of Preclinical Data Showing Radioenhancer NBTXR3 May "Reprogram" the Tumor Microenvironment to Overcome Anti-PD-1 Resistance and Evoke Abscopal Effect
28 Sep, 2021 Yahoo! Finance

PARIS & CAMBRIDGE, Mass., September 28, 2021--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanophysics-based approaches to expand treatment possibilities for patients with cancer, today announced the publication of preclinical findings with the University of Texas MD Anderson Cancer Center (MD Anderson) in the International Journal of Radiation Oncology, Biology, Physics (Red Journal). These data support t

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
17 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
14 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Friday's Intraday Session
10 Sep, 2021 FinancialContent

Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 63.11% to $14.18 during Friday's regular session. IVERIC ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
10 Sep, 2021 FinancialContent

Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The ...

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital as of August 31, 2021
09 Sep, 2021 FinancialContent

Regulatory News:

NANOBIOTIX Provides Business Update and Reports Financial Results for the First Half of 2021
08 Sep, 2021 FinancialContent

Regulatory News:

Earnings Scheduled For September 8, 2021
08 Sep, 2021 FinancialContent

Companies Reporting Before The Bell • Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first ...

Nanobiotix to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep, 2021 FinancialContent

Nanobiotix To Present at the 23rd Annual H.C. Wainwright Global Investment Conference

Earnings Scheduled For September 3, 2021
03 Sep, 2021 FinancialContent

Companies Reporting After The Bell • IRSA Propiedades (NASDAQ:IRCP) is projected to report earnings for its fourth ...

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital as of July 31, 2021
06 Aug, 2021 Yahoo! Finance

PARIS, August 06, 2021--Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX):

Nanobiotix Provides Second Quarter Operational and Financial Update
20 Jul, 2021 FinancialContent

Nanobiotix (Euronext: NANO – NASDAQ: NBTX) provides second quarter operational and financial update.

12 Health Care Stocks Moving In Wednesday's Intraday Session
14 Jul, 2021 FinancialContent

Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX) stock moved upwards by 17.2% to $1.43 during Wednesday's regular session. Trading ...

Nanobiotix Starts New NBTXR3 Study In Lung Cancer Patients
01 Jul, 2021 FinancialContent

Nanobiotix(NASDAQ: NBTX)initiated a new Phase 1 studyevaluating NBTXR3 activated by radiation therapy (RT) for ...

NANOBIOTIX Announces Initiation of New Clinical Study Evaluating NBTXR3 in Lung Cancer
30 Jun, 2021 FinancialContent

Regulatory News:

Do Hedge Funds Love Nanobiotix S.A. (NBTX)?
23 Jun, 2021 Yahoo! Finance

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 866 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of March 31st, 2020. […]

NANOBIOTIX to Host Virtual KOL Event Discussing Potential First-in-Class Radioenhancer NBTXR3 In Immunotherapy on June 11, 2021
07 Jun, 2021 FinancialContent

Regulatory News:

The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
04 Jun, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Nanobiotix's Nanoparticle Technology Shows Tumor-Killing Effect in Early-Stage Head & Neck Cancer
04 Jun, 2021 FinancialContent

Nanobiotix(NASDAQ: NBTX), ahead of the 2021 Annual Meeting of the American Society for Clinical Oncology meeting, has said that ...

Nanobiotix S.A (NBTX) is a NASDAQ Common Stock listed in , ,

970x250